All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
Fri 1980-03-28? to Fri 2025-02-14 |
YTD
Return |
TR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
+6.95%
2025-02-14 |
456.12 TR
2025-02-14 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Fri 1980-03-28? to Fri 2025-02-14 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+45,511.60%
+14.62%/yr |
+11.42%/yr
(R2=0.842) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Fri 1980-03-28? to Fri 2025-02-14 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1980-03-28 |
$4,561,160.15
2025-02-14 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | +6.95% |
2024 | −5.11% |
2023 | +9.72% |
2022 | +2.57% |
2021 | +28.43% |
2020 | −16.77% |
2019 | +30.71% |
2018 | +15.24% |
2017 | −1.82% |
2016 | +3.71% |
2015 | +1.00% |
2014 | −14.68% |
2013 | +30.35% |
2012 | +1.92% |
2011 | +24.07% |
2010 | −0.93% |
2009 | +20.74% |
2008 | −21.38% |
2007 | +0.09% |
2006 | +8.73% |
2005 | +10.67% |
2004 | +6.57% |
2003 | +29.81% |
2002 | −20.79% |
2001 | −9.26% |
2000 | +5.06% |
1999 | −17.54% |
1998 | +48.87% |
1997 | +57.04% |
1996 | +19.10% |
1995 | +47.02% |
1994 | +4.38% |
1993 | −10.04% |
1992 | −22.38% |
1991 | +100.11% |
1990 | +31.50% |
1989 | +39.56% |
1988 | +7.33% |
1987 | +21.50% |
1986 | +38.97% |
1985 | +75.24% |
1984 | +26.25% |
1983 | −1.83% |
1982 | +156.51% |
1981 | +27.02% |
1980 | +25.09% |
Fri 1980-03-28? to Fri 2025-02-14 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −19.32% |
−54.70%
1993-08-13 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||